Lupin Launches Azilsartan Medoxomil Tablets in US
Lupin has launched Azilsartan Medoxomil Tablets in the US, a bioequivalent generic version of Edarbi, indicated for the treatment of hypertension in adults.
Lupin Pharmaceuticals | 17/06/2026 | By News Bureau
US FDA Completes Pre-Approval Inspection at Lupin's Somerset Facility with One Observation
The US Food and Drug Administration (FDA) has completed a pre-approval inspection of Lupin’s manufacturing facility in Somerset, New Jersey, USA, with one observation.
Lupin Pharmaceuticals | 11/10/2025 | By Dineshwori | 553
Lupin Pharmaceuticals | 23/01/2023 | By Sudeep Soparkar | 1340
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy